ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.63
-0.02 (-0.35%)
Jun 8, 2026, 4:00 PM EDT - Market closed

ImageneBio Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, ImageneBio stock has a consensus rating of "Buy" and an average price target of $13. The average 1-year stock price forecast is 130.91% higher than the current stock price, while the lowest is $2.00 (-64.48%) and the highest is $24 (+326.29%).

Price Target: $13 (+130.91%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$2.00$13$13$24
Change-64.48%+130.91%+130.91%+326.29%

Analyst Ratings

The average analyst rating for ImageneBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26May '26
Strong Buy222222
Buy000000
Hold000000
Sell000000
Strong Sell111111
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wedbush
Wedbush
Sell
Maintains
$2
SellMaintains$2-64.48%May 11, 2026
Leerink Partners
Leerink Partners
Buy
Maintains
$30$24
BuyMaintains$30$24+326.29%May 8, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 8, 2026

Financial Forecast

Revenue This Year
n/a
from 800.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-4.48
from -9.64
EPS Next Year
-3.98
from -4.48
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
7.96M3.50M800.00K-
Revenue Growth
--56.04%-77.14%-100.00%
Operating Income
-21.93M-37.00M-48.45M-58.24M
Net Income
-21.15M-36.57M-45.35M-55.00M
EPS
---9.64-4.48
No. Analysts
---3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-100.0%
Avg
-100.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-3.57
Avg-4.48
Low-5.39

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-